BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 10, 2019
View Archived Issues
Staph toxin does double duty
Read More
Large-scale identification of regulatory targets
Read More
Basilea reports interim data from phase II study of derazantinib in iCCA with FGFR2 gene fusions
Read More
Lysogene initiates phase II/III study of its AAV/rh.10-SGSH gene therapy
Read More
Cellular Biomedicine begins enrollment in phase I study of C-CAR088 for multiple myeloma in China
Read More
Discovery of a novel series of IDH1 inhibitors with promising preclinical activity
Read More
Identification of novel SSTR5-selective antagonists with improved stability and pharmacokinetics
Read More
Interaction of CSF with graphene causes changes in its vibrational energies that distinguish ALS
Read More
Competitive single molecule arrays for highly sensitive detection of small molecules
Read More
Development of the first class of YEATS domain inhibitors by targeting the pi-pi-pi stacking
Read More
New nanoformulations for oral delivery of antiparasitic triclabendazole with better bioavailability
Read More
EMBL patents pirin-targeting compounds
Read More
Synthetic sodium channel blockers demonstrate anticancer effects in prostate cancer cells
Read More
Genentech and Roche present new IRAK-4 inhibitors
Read More
NIAID analysis shows phase IIb study of FLU-v met primary endpoint
Read More
NIAID studies rCSP malaria vaccine with and without adjuvant in healthy subjects
Read More
New phase I trial studies GPC3-CAR-T cells in pediatric GPC3-positive solid tumors
Read More
Relugolix receives first approval in Japan for the treatment of uterine fibroids
Read More
Osteoporosis genetic atlas identifies potential new drug targets
Read More
Combination beta-lactamase inhibitor and antibiotic product Zarvaxa approved in Japan
Read More
Opdivo demonstrates significant extension in OS in phase III ATTRACTION-3 study
Read More
Enterin initiates phase IIb KARMET study of ENT-01
Read More
Sirion Biotech collaborates with Denali Therapeutics to develop gene therapies for CNS diseases
Read More
Vizimpro approved in Japan for the treatment of EGFR-mutated NSCLC
Read More
